Investing.com - IsoPlexis reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
IsoPlexis announced earnings per share of $-0.47 on revenue of $4.48M. Analysts polled by Investing.com anticipated EPS of $-0.42 on revenue of $4.63M.
IsoPlexis shares are down 24% from the beginning of the year , still down 89.62% from its 52 week high of $16.95 set on Friday, November 19, 2021.
IsoPlexis shares lost 3.41% in pre-market trade the report.
IsoPlexis follows other major Healthcare sector earnings this month
IsoPlexis's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar